Griffiths, P. D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., . . . Burroughs, A. K. (2011). Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial. Lancet Publishing Group.
シカゴスタイル引用形Griffiths, Paul D., et al. Cytomegalovirus Glycoprotein-B Vaccine With MF59 Adjuvant in Transplant Recipients: A Phase 2 Randomised Placebo-controlled Trial. Lancet Publishing Group, 2011.
MLA引用形式Griffiths, Paul D., et al. Cytomegalovirus Glycoprotein-B Vaccine With MF59 Adjuvant in Transplant Recipients: A Phase 2 Randomised Placebo-controlled Trial. Lancet Publishing Group, 2011.
警告: この引用は必ずしも正確ではありません.